Bleeding Time and Clotting Time

Function

The Bleeding Time (BT) and Clotting Time (CT) tests are fundamental screening tools used to assess the body's hemostatic mechanisms. Bleeding Time primarily measures the vascular phase and platelet function—essentially how quickly small blood vessels constrict and platelets form a 'plug' to stop bleeding. Clotting Time measures the efficiency of the coagulation cascade and the formation of a stable fibrin clot.

Why it is Ordered

These tests are frequently ordered as part of a pre-operative workup to ensure a patient can safely undergo surgery without excessive blood loss. They are also used to investigate symptoms of bleeding disorders, such as frequent nosebleeds, easy bruising, or heavy menstrual cycles. While more sophisticated tests like PT/INR or PTT have largely superseded CT in modern labs, BT remains a bedside indicator of platelet activity.

Associated Conditions

Abnormal results in these tests are associated with several conditions:

• Thrombocytopenia: A low platelet count leads to prolonged bleeding time.
• Von Willebrand Disease: A common hereditary disorder affecting platelet adhesion.
• Hemophilia: Genetic disorders (A or B) that deficiency specific clotting factors (VIII or IX), primarily affecting the clotting time.
• Vitamin K Deficiency: Essential for the synthesis of several coagulation factors.
• Liver Disease: Since the liver produces most clotting factors, hepatic failure significantly prolongs clotting time.
• Medication Effects: The use of aspirin, NSAIDs, or anticoagulants (Warfarin, Heparin) will alter these results significantly.